Team:AITM-Nepal/Overview

From 2013.igem.org

(Difference between revisions)
Line 205: Line 205:
<div class="maincontents">
<div class="maincontents">
<iframe width="640" height="480" src="//www.youtube.com/embed/biItYFKRLXM" frameborder="1" allowfullscreen></iframe>
<iframe width="640" height="480" src="//www.youtube.com/embed/biItYFKRLXM" frameborder="1" allowfullscreen></iframe>
 +
<br>
 +
<p>
 +
The main cause of infection from any kind of pathogen is common indeed. The inefficient immune activation and working is the step after which there is the case for the disease progression. But what if we could avert the disease before we know we have harvested disease or any infection.</p>
 +
<p>This is the theme of the project. We aim to engineer E. coli so that it will boost the immune activation by selectively upgrading the Interferon type one molecules production inside human body.
 +
</p>
</div>
</div>

Revision as of 02:47, 28 September 2013


The main cause of infection from any kind of pathogen is common indeed. The inefficient immune activation and working is the step after which there is the case for the disease progression. But what if we could avert the disease before we know we have harvested disease or any infection.

This is the theme of the project. We aim to engineer E. coli so that it will boost the immune activation by selectively upgrading the Interferon type one molecules production inside human body.